The Effect of Timeliness of Care on Lung Cancer Survival – A Population-Based Approach
References
- Vinas F, Ben Hassen I, Jabot L, Monnet I, Chouaid C. Delays for diagnosis and treatment of lung cancers: A systematic review. Clin Respir J. 2016; 10(3): 267–71. DOI: 10.1111/crj.12217
- Institute for Health Metrics and Evaluation (IHME).
Portugal Profile . Seattle, WA: IHME, University of Washington, 2021. Available fromhttp://www.healthdata.org/[PORTUGAL] . Assessed [08/04/2022]. - Lo DS, Zeldin RA, Skrastins R, Fraser IM, Newman H, Monavvari A, et al. Time to treat: A system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol [Internet]. 2007; 2(11): 1001–6. DOI: 10.1097/JTO.0b013e318158d4b6
- Institute of Medicine. Book: Crossing the Quality Chasm: A New Health System for the 21st Century. Vol. 323, Bmj. Washington, DC: The National Academies Press; 2001. 1–360 p. DOI: 10.1136/bmj.323.7322.1192
- Ost DE, Yeung SCJ, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 SUPPL): 121–41. DOI: 10.1378/chest.12-2352
- Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med. 2018; 141: 172–9. DOI: 10.1016/j.rmed.2018.07.005
- Mak KS, Van Bommel ACM, Stowell C, Abrahm JL, Baker M, Baldotto CS, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J [Internet]. 2016; 48(3): 852–60. DOI: 10.1183/13993003.02049-2015
- Gould MK, Ghaus SJ, Olsson JK, Schultz EM. Timeliness of care in veterans with non-small cell lung cancer. Chest [Internet]. 2008; 133(5): 1167–73. DOI: 10.1378/chest.07-2654
- Nadpara P, Madhavan SS, Tworek C. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study. Cancer Epidemiol. 2015; 39(6): 1136–44. DOI: 10.1016/j.canep.2015.06.005
- Anggondowati T, Ganti AK, Islam KMM. Impact of time-to-treatment on overall survival of non-small cell lung cancer patients — An analysis of the national cancer database. Transl Lung Cancer Res. 2020; 9(4): 1202–11. DOI: 10.21037/tlcr-19-675
- Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22(2): 315–21. DOI: 10.1200/JCO.2004.08.136
- Philip J, Husdon P, Bostanci A, Street A, Horey DE, Aranda S, et al. Metastatic non-small cell lung cancer: A benchmark for quality end-of-life cancer care? MJA. 2015; 202(3): 139–44. DOI: 10.5694/mja14.00579
- Casebeer A, Antol DD, DeClue RW, Hopson S, Li Y, Khoury R, et al. The relationship between guideline-recommended initiation of therapy, outcomes, and cost for patients with metastatic non-small cell lung cancer. J Manag Care Spec Pharm. 2018; 24(6): 554–64. DOI: 10.18553/jmcp.2018.24.6.554
- WHO.
ICD-10 International Statistical Classification of Diseases and Related Health Problems . World Heal Organ [Internet]. 2010; (2010 Edition). Available from:https://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf?ua=1 - Verdasca J, Costa FA, Ramos C, Murteira R, Miranda A. The south region cancer registry: An evaluation of its exhaustiveness in a cohort of lung cancer patients. Thorac Cancer. 2019; 10(2): 330–4. DOI: 10.1111/1759-7714.12915
- Lewis D, Check D, Caporaso N, Travis W, Devesa S. U.S. lung cancer trends by histologic type. Cancer. 2014; 120(18): 2883–92. DOI: 10.1002/cncr.28749
- The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax. 1998; 53(Suppl 1): 1–8. DOI: 10.1136/thx.53.suppl_1.S1
- Asch S, Kerr E, Hamilton E, Reifel J, Mcglynn EA. Quality of care for oncologic conditions and HIV: A review of the literature and quality indicators [Internet]. RAND Health, supported by the Agency for Healthcare Research and Quality; 2000. p. 1–300. Available from:
papers3://publication/uuid/264DAC47-C3C2-4DBE-94A4-4142C7B1BFD5 - Dawson B, Trapp RG. Basic & Clinical Biostatistics. Fourth ed. LANGE/McGraw-Hill. 2004.
- Guerreiro T, Antunes L, Bastos J, Mayer A, Forjaz G, Araujo A, et al. Lung cancer: A nationwide study to characterize sex differences, incidence, and spatial patterns in Portugal. In Vivo (Brooklyn). 2020; 34: 2711–9. DOI: 10.21873/invivo.12092
- Lautamäki A, Gunn J, Sipilä J, Rautava P, Sihvo E, Kytö V. Women have a higher resection rate for lung cancer and improved survival after surgery. Interact Cardiovasc Thorac Surg. 2021; 32(6): 889–95. DOI: 10.1093/icvts/ivab006
- Andreano A, Valsecchi MG, Russo AG, Siena S, Andruccioli M, Ardizzoia A, et al. Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases. Arch Public Heal. 2021; 79(1): 1–13. DOI: 10.1186/s13690-021-00528-0
- Bullard JT, Eberth JM, Arrington AK, Adams SA, Cheng X, Salloum RG. Timeliness of treatment initiation and associated survival following diagnosis of Non–Small-Cell lung cancer in South Carolina. South Med J. 2017; 110(2): 107–13. DOI: 10.14423/SMJ.0000000000000601
- Matheson LM, Pitson G, Yap CH, Singh M, Collins I, Campbell P, et al. Measuring the quality of cancer care in the Barwon south western region, Victoria, Australia. Int J Qual Heal Care. 2020; November: 1–9. DOI: 10.1093/intqhc/mzaa145
- Stokstad T, Sørhaug S, Amundsen T, Grønberg BH. Medical complexity and time to lung cancer treatment – A three-year retrospective chart review. BMC Health Serv Res [Internet]. 2017; 1–9. DOI: 10.1186/s12913-016-1952-y
- Forrest LF, Adams J, White M, Rubin G. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: Population-based, data-linkage study. Br J Cancer [Internet]. 2014; 111(9): 1843–51. DOI: 10.1038/bjc.2014.472
- Vrijens F, De Gendt C, Verleye L, Robays J, Schillemans V, Camberlin C, et al. Quality of care and variability in lung cancer management across Belgian hospitals: A population-based study using routinely available data. Int J Qual Heal Care. 2018; 30(4): 306–12. DOI: 10.1093/intqhc/mzy027
- Bylicki O, Didier M, Riviere F, Margery J, Grassin F, Chouaid C. Lung cancer and end life care: A systematic review and thematic synthesis of aggressive inpatient care. BMJ Support Palliat Care. 2019; 9: 413–24. DOI: 10.1136/bmjspcare-2019-001770
- Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, et al. Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in seven developed countries. JAMA – J Am Med Assoc. 2016; 315(3): 272–83. DOI: 10.1001/jama.2015.18603
- Hu Y, McMurry TL, Wells KM, Isbell JM, Stukenborg GJ, Kozower BD. Postoperative mortality is an inadequate quality indicator for lung cancer resection. Ann Thorac Surg. 2014; 97(3): 973–9. DOI: 10.1016/j.athoracsur.2013.12.016
- Caldarella A, Amunni G, Angiolini C, Crocetti E, Di costanzo F, Di leo A, et al. Feasibility of evaluating quality cancer care using registry data and electronic health records: A population-based study. Int J Qual Heal Care. 2012; 24(4): 411–8. DOI: 10.1093/intqhc/mzs020
- Cassivi SD, Allen MS, Vanderwaerdt GD, Ewoldt LL, Cordes ME, Wigle DA, et al. Patient-centered quality indicators for pulmonary resection. Ann Thorac Surg. 2008; 86(3): 927–32. DOI: 10.1016/j.athoracsur.2008.04.021
- Jakobsen E, Palshof T, Østerlind K, Pilegaard H. Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results. Eur J Cardio-thoracic Surg. 2009; 35(2): 348–52. DOI: 10.1016/j.ejcts.2008.09.026
- Guerreiro T, Forjaz G, Antunes L, Bastos J, Mayer A, Aguiar P, et al. Lung cancer survival and sex-specific patterns in Portugal: A population-based analysis. Pulmonology. 2021; 18: 52 DOI: 10.1016/j.pulmoe.2021.09.001
- Maiga AW, Deppen SA, Pinkerman R, Massion PP, Dittus RS, Lambright ES, et al. Timeliness of care and lung cancer tumor-stage progression: How long can we wait? Ann Thorac Surg. 2017; 104(6): 1791–7. DOI: 10.1016/j.athoracsur.2017.06.051
- Olsson JK, Schultz EM, Gould MK. Timeliness of care in patients with lung cancer: A systematic review. Thorax. 2009; 64(9): 749–56. DOI: 10.1136/thx.2008.109330
- Tanvetyanon T. Quality-of-Care indicators for non–small cell lung cancer. Cancer Control. 2009; 16(4): 335–41. DOI: 10.1177/107327480901600408
DOI: https://doi.org/10.5334/aogh.3845 | Journal eISSN: 2214-9996
Language: English
Submitted on: May 15, 2022
Accepted on: May 9, 2023
Published on: Jun 5, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Teresa Guerreiro, Alexandra Mayer, Pedro Aguiar, António Araújo, Carla Nunes, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.